We report that people with MS have higher plasma levels of neuronal damage markers (NFL, GFAP), cytokines/cytokine receptors (IL15, IL17RB, IL22), and lower levels of several proteins, including integrins and cystatin D, compared with healthy controls. The gene discussed is NEFL; the disease is myeloid sarcoma.